OHC - Oncology Hematology Care

November is Stomach Cancer Awareness Month. Did you know lifestyle changes like quitting smoking and eating a diet rich in fruits and vegetables can potentially reduce your risk of developing stomach cancer? If you are concerned about any new symptoms, be sure to speak with your healthcare provider. Learn more about stomach cancer, including the signs and symptoms to watch for. https://lnkd.in/gABhnQAr #StomachCancerAwareness #CancerAwarenessMonth #NutritionMatters #HealthyLifestyle #HealthEducation #CancerPrevention

Connie Rudy, MSN, APRN is one of our esteemed advanced practice providers. She sees patients at the OHC West location and has completed additional training in supportive care to enhance her skills in patient care. Here, Connie explains what radiation therapy is and why it's a powerful treatment option for cancer. To learn more about Connie or our other advanced practice providers, visit ohcare.com. #AdvancedPracticeProvider #RadiationTherapy #CancerTreatment #SupportiveCare #HealthcareProfessionals #OncologyCare

As a continued part of lung cancer awareness month, knowing the risk factors can help you reduce your risk of being diagnosed. Having one or more of these common risk factors for lung cancer does not mean you will develop lung cancer, but there are steps you can take to reduce your risk and stay healthy. Talk to your healthcare provider if you have any concerns. #LungCancerAwareness #CancerPrevention #LungHealth #HealthTips #AwarenessMonth #KnowTheRisks #CancerAwareness

OHC radiation oncologist Marc R. Mosbacher, MD, specializes in stereotactic radiosurgery for brain and lung metastases, intensity-modulated radiation therapy (IMRT) for head and neck tumors, and three-dimensional conformal radiation therapy (3D-CRT) for lung and breast tumors. Dr. Mosbacher believes in providing patients with the most advanced care possible, stating, “I have the greatest respect for my patients, so my work is driven by the fundamentals of providing the latest treatments with compassionate care. It’s especially rewarding for me to deliver care that maximizes their chance of beating their disease." Read several of Dr. Mosbacher's recent reviews below. To schedule an appointment with Dr. Mosbacher, visit ohcare.com today. #RadiationOncology #IMRT #CancerCare #PatientCare #OncologySpecialist #CompassionateCare

OHC advanced practice provider Tiffany Jones, MSN, APRN, and financial navigator Alison Mulholland recently spoke at The Leukemia & Lymphoma Society Ask The Expert panel discussion. Along with the rest of the panel, the pair answered questions about side effect management, navigating the cancer journey, the cost of cancer care, and other crucial topics for local blood cancer patients, survivors, and family members. Thank you LLS for offering our OHC experts the chance to help patients and caregivers understand the complex nature of cancer care and explain how OHC provides patients with everything they need to beat cancer. #CancerCare #BloodCancer #LLS #PatientSupport #HealthcareHeroes #PatientEducation

Did you know people who quit smoking cut their risk of lung cancer by up to 50% after 10 years compared to people who keep smoking? Flip through the images to read the benefits to quitting smoking, at any age. #QuitSmoking #LungHealth #HealthyLiving #SmokingCessation #CancerAwareness #SmokeFree

On Veterans Day, we would like to recognize and honor the men and women who have served our country. Thank you for your service! #VeteransDay #ThankYouVeterans #HonoringHeroes

OHC medical oncologist and hematologist david waterhouse, MD, MPH, recently published additional findings from the revolutionary CodeBreak 200 trial that led to the FDA approval of sotorasib for the treatment of non-small cell lung cancer for patients with the KRAS gene mutation. Dr. Waterhouse states, “Sotorasib was the first agent to successfully target KRAS. This target has been very difficult to address despite the fact that we have known about it for nearly 40 years.? The approval was based on the improved progression-free survival and patient-reported outcomes (PROs)." The PROs were a contributing factor to the FDA's approval, and this new paper explains in detail the PROs from the study and why they are important to consider for new therapies. Read more here: https://lnkd.in/gKaCMY5K #NSCLC #KRAS #CancerResearch #MedicalOncology #ClinicalTrials #PatientOutcomes #CancerTreatment

Have you met OHC advanced practice provider Libby Sorosiak, MSN, APRN, FNP-C? Libby is a dedicated caregiver who recently joined the OHC Supportive Care Program. As a member of this program, Libby works with your healthcare team to assess your treatment goals, symptom management, and quality of life. She will connect you with community services as needed and help provide more support during treatment to help you achieve the best possible outcome. Libby sees patients at the OHC Fairfield location. To schedule time with Libby, please contact your care team to request a supportive care appointment. #SupportiveCare #HealthcareProfessionals #PatientCare #QualityOfLife #AdvancedPracticeProvider

This is what hope looks like. Mary collapsed at work, a CT scan showed a brain tumor. Thankfully, Mary found Dr. Vincent DiNapoli, MD, PhD, FAANS, Neurosurgeon, at the Mayfield Brain & Spine Center & Dr. Betsy Levick, Radiation Oncologist, at OHC - Oncology Hematology Care. "The future is bright, I'm really a believer in GammaTile." - Dr. Betsy Levick Mary, a patient diagnosed with a glioblastoma, was treated with GammaTile Therapy at Mayfield Brain & Spine in Cincinnati. She and her husband, Tony, share their experience with Mary's tumor, from diagnosis to treatment, while her team at Mayfield and OHC, provide their perspectives on adopting "future-brightening" technology like GammaTile Therapy. GT Medical Technologies, Inc. #QualityOfLife | #RadiationOncology | #Neurosurgery